Índice

• • ·Editorial Board

    Página :CO2

    

• Alcohol abuse and its consequences

  • ·Alcohol misuse in bipolar disorder. A systematic review and meta-analysis of comorbidity rates

    Página :117-124

    A. Di Florio, N. Craddock, M. van den Bree

    Resumen Resumen Esquema Esquema   
  • ·Impaired decision-making and brain shrinkage in alcoholism

    Página :125-133

    A.-P. Le Berre, G. Rauchs, R. La Joie, F. Mézenge, C. Boudehent, F. Vabret, S. Segobin, F. Viader, P. Allain, F. Eustache, A.-L. Pitel, H. Beaunieux

    Resumen Resumen Esquema Esquema  

• Bipolar disorder

  • ·Psychoeducation and cognitive-behavioral therapy for patients with refractory bipolar disorder: A 5-year controlled clinical trial

    Página :134-141

    A. González Isasi, E. Echeburúa, J.M. Limiñana, A. González-Pinto

    Resumen Resumen Esquema Esquema  
  • ·Role of DRD2 and ALDH2 genes in bipolar II disorder with and without comorbid anxiety disorder

    Página :142-148

    Y.-S. Wang, S.-Y. Lee, S.-L. Chen, Y.-H. Chang, T.-Y. Wang, S.-H. Lin, C.-L. Wang, S.-Y. Huang, I.H. Lee, P.S. Chen, Y.K. Yang, R.-B. Lu

    Resumen Resumen Esquema Esquema

• Schizophrenia and psychosis

  • ·Age of onset group characteristics in forensic patients with schizophrenia

    Página :149-152

    D. Vinokur, S.Z. Levine, D. Roe, A. Krivoy, T. Fischel

    Resumen Resumen Esquema Esquema  
  • ·Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?

    Página :153-159

    J. Lyne, L. Renwick, K. Madigan, B. O’Donoghue, M. Bonar, T. Grant, A. Kinsella, K. Malone, N. Turner, E. O’Callaghan, M. Clarke

    Resumen Resumen Esquema Esquema
  • ·Working memory dysfunction in schizophrenia patients with obsessive-compulsive symptoms: An fMRI study

    Página :160-166

    M. Bleich-Cohen, T. Hendler, R. Weizman, S. Faragian, A. Weizman, M. Poyurovsky

    Resumen Resumen Esquema Esquema  
  • ·Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: Severe negative syndrome may be related to a distinct lipid pathophysiology

    Página :167-171

    S.-F. Chen, T.-M. Hu, T.-H. Lan, H.-J. Chiu, L.-Y. Sheen, E.-W. Loh

    Resumen Resumen Esquema Esquema
  • ·Allelic variants in the zinc transporter-3 gene, SLC30A3, a candidate gene identified from gene expression studies, show gender-specific association with schizophrenia

    Página :172-178

    C. Perez-Becerril, A.G. Morris, A. Mortimer, P.J. McKenna, J. de Belleroche

    Resumen Resumen Esquema Esquema   

• Pharmacotherapy and its consequences

  • ·Dysmetabolic features of the overweight patients receiving antipsychotic drugs: A comparison with normal weight and obese subjects

    Página :179-182

    P. Manu, C.-U. Correll, M. Wampers, R. van Winkel, W. Yu, D. Shiffeldrim, M. De Hert

    Resumen Resumen Esquema Esquema
  • ·Patient satisfaction with psychotropic drugs: Validation of the PAtient SAtisfaction with Psychotropic (PASAP) scale in patients with bipolar disorder

    Página :183-190

    C. Nordon, B. Falissard, S. Gerard, J. Angst, J.M. Azorin, A. Luquiens, C. Reed, M. Lukasiewicz, I. Gasquet

    Resumen Resumen Esquema Esquema  
  • ·Improved quality of life over one year is associated with improved adherence in patients with schizophrenia

    Página :191-196

    K.P. Hayhurst, R.J. Drake, J.A. Massie, G. Dunn, T.R.E. Barnes, P.B. Jones, S.W. Lewis

    Resumen Resumen Esquema Esquema